Slow Capital, Inc. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Slow Capital, Inc. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$3,006,089
-16.1%
66,228
+3.8%
0.55%
-11.3%
Q2 2023$3,583,024
+18.8%
63,823
-4.3%
0.62%
+10.3%
Q1 2023$3,016,932
+15.1%
66,702
+3.5%
0.56%
-3.3%
Q4 2022$2,620,990
-9.2%
64,477
+45.9%
0.58%
-6.6%
Q3 2022$2,887,000
+5.1%
44,182
-2.3%
0.62%
-6.4%
Q2 2022$2,748,000
+3.4%
45,218
+6.8%
0.67%
+34.5%
Q1 2022$2,657,000
+15.7%
42,332
+39.7%
0.50%
+26.5%
Q4 2021$2,296,000
+9.9%
30,297
+62.3%
0.39%
+2.3%
Q3 2021$2,090,000
-30.6%
18,668
+0.3%
0.38%
-32.8%
Q2 2021$3,013,000
+27.2%
18,614
+13.6%
0.57%
+10.9%
Q1 2021$2,369,000
-5.1%
16,387
+0.5%
0.51%
-13.8%
Q4 2020$2,495,000
+86.3%
16,300
+1.7%
0.60%
+63.3%
Q3 2020$1,339,000
+39.6%
16,020
+22.8%
0.36%
+29.4%
Q2 2020$959,000
+75.0%
13,043
+1.0%
0.28%
+36.2%
Q1 2020$548,000
-45.6%
12,913
-21.9%
0.21%
-33.4%
Q4 2019$1,007,000
+88.2%
16,524
+26.5%
0.31%
+64.6%
Q3 2019$535,000
-14.1%
13,062
-1.3%
0.19%
-26.5%
Q2 2019$623,000
+29.3%
13,237
-1.8%
0.26%
+33.9%
Q1 2019$482,00013,4850.19%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders